Preloader Close
  • Twisted nanophotonic technology for integrated chiroptical sensing of drugs on a chip
At a glance


Project Focus

Chirality is the asymmetric property of an object that makes it distinguishable from its mirror image

Project Objectives

TwistedNano targets the EU priority area “Health and Safety” by developing a set of new-generation

Project Organization

The workplan structure is based on a strong collaboration between all partners

TwistedNano will be developed by a consortium of 6 European Academic Institutions (UnivAQ – Università degli Studi dell’Aquila, Italy,  MPL – Max Planck Institute for The Science of Light, Germany, EPFL – Ecole Polytechnique Fédérale de Lausanne, Switzerland, CNRS – Centre national de la recherche scientifique, France, IIT – Istituto Italiano di Tecnologia, Italy, and ICFO – The Institute of Photonic Sciences, Spain), a global industrial player in pharmaceutics (Dompé Farmaceutici S.p.A., Italy) and a young start-up(Foresee Biosystems, Italy).


TwistedNano aims at developing an innovative platform to measure tiny amounts of chiral drugs.


Recent scientific articles

Crossing of the Branch Cut: The Topological Origin of a Universal 2π-Phase Retardation in Non-Hermitian Metasurfaces

R. Colom, E. Mikheeva, K. Achouri, J. Zuniga-Perez, N. Bonod, Olivier J. F. Martin, S. Burger, P. Genevet
Laser Photonics, Rev. 2023, 2200976

Universal Active Metasurfaces for Ultimate Wavefront Molding by Manipulating the Reflection Singularities

M. Elsawy, C. Kyrou, E. Mikheeva, R. Colom, J-Y. Duboz, K. Z. Kamali, S. Lanteri, D. Neshev, P. Genevet
Laser Photonics , Rev. 2023, 220880 [HAL Id: hal-03994382]

Project details


48 months
Andrea Marini (UNIVAQ)